LENZ Therapeutics, Inc. vs Otonomy
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- LENZ Therapeutics, Inc. and Otonomy are worth about the same: $110 M and $113 M (market caps of Oct 30, 2026 for LENZ Therapeutics, Inc. and Jan 7, 2022 for Otonomy). Otonomy's value is the last on file, from Jan 7, 2022: no market-data feed is connected for its exchange yet.
- LENZ Therapeutics, Inc. had more revenue: $19 M in the year to December 2025 against $0 M for Otonomy in the year to December 2020.
- Both made a net loss: $82 M for LENZ Therapeutics, Inc. and $45 M for Otonomy.
- LENZ Therapeutics, Inc. keeps more of each dollar of sales: a net margin of -430.2% against -16555.6% for Otonomy.
Market value, the same start = 100
From Jan 2022: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Not enough data yet.
Side by side
| Measure | LENZ Therapeutics, Inc. LENZ · #18,419 in the world | Otonomy OTIC |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Founded | — | 2008 |
| Size | ||
| Market cap | $110 M | $113 M* |
| Revenue | $19 M | $0 M |
| Net income | $-82 M | $-45 M▲ best |
| Employees | 152 | — |
| Valuation | ||
| Price to sales | 5.7× | — |
| Price to book | 0.4× | — |
| Free cash flow yield | -63.8% | — |
| Profitability | ||
| Gross margin | 97.8% | — |
| Operating margin | -477.4% | — |
| Net margin | -430.2% | — |
| Return on equity | -33.6% | — |
| Cash | ||
| Free cash flow margin | -366.7% | — |
| Altman Z-score zone | grey | — |
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap Jan 2022 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, LENZ Therapeutics, Inc. or Otonomy?
LENZ Therapeutics, Inc. and Otonomy are worth about the same: $110 M and $113 M (market caps of Oct 30, 2026 for LENZ Therapeutics, Inc. and Jan 7, 2022 for Otonomy). Otonomy's value is the last on file, from Jan 7, 2022: no market-data feed is connected for its exchange yet.
Which makes more money, LENZ Therapeutics, Inc. or Otonomy?
LENZ Therapeutics, Inc. had more revenue: $19 M in the year to December 2025 against $0 M for Otonomy in the year to December 2020. Both made a net loss: $82 M for LENZ Therapeutics, Inc. and $45 M for Otonomy.
Which is more profitable, LENZ Therapeutics, Inc. or Otonomy?
LENZ Therapeutics, Inc. keeps more of each dollar of sales: a net margin of -430.2% against -16555.6% for Otonomy.
More about LENZ Therapeutics, Inc.
More about Otonomy
Sources#
Every figure on this page comes from these, with the date shown next to it.